Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER-SLEEP
NCT06404086Phase 2Completed
- Sponsor
- Duke University
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of modafinil, solriamfetol, melatonin in post-COVID-19 condition (PCC), Hypersomnia (HS), sleep disorder, sponsored by Duke University. Started Jul 2024; status: completed.
02
Drugs
modafinilsolriamfetolmelatonin
03
Conditions
post-COVID-19 condition (PCC)Hypersomnia (HS)sleep disorder
Beyond the preview
Go deeper on NCT06404086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06404086.